X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
argatroban (539) 539
humans (404) 404
heparin-induced thrombocytopenia (283) 283
heparin - adverse effects (240) 240
index medicus (235) 235
thrombocytopenia - chemically induced (232) 232
anticoagulation (197) 197
hematology (194) 194
anticoagulants - adverse effects (188) 188
heparin (182) 182
male (182) 182
female (168) 168
anticoagulants - therapeutic use (163) 163
pipecolic acids - therapeutic use (153) 153
peripheral vascular disease (148) 148
thrombosis (144) 144
middle aged (135) 135
anticoagulants (134) 134
thrombocytopenia (132) 132
thrombocytopenia - drug therapy (132) 132
aged (123) 123
lepirudin (123) 123
bivalirudin (114) 114
therapy (105) 105
recombinant hirudin (104) 104
pharmacology & pharmacy (100) 100
molecular-weight heparin (96) 96
cardiopulmonary bypass (94) 94
pipecolic acids - administration & dosage (94) 94
anticoagulants - administration & dosage (88) 88
direct thrombin inhibitors (80) 80
antibodies (76) 76
adult (71) 71
treatment outcome (71) 71
management (70) 70
diagnosis (69) 69
fondaparinux (69) 69
retrospective studies (69) 69
thrombin (69) 69
recombinant proteins - therapeutic use (67) 67
thrombin - antagonists & inhibitors (63) 63
unfractionated heparin (63) 63
partial thromboplastin time (59) 59
warfarin (59) 59
cardiac & cardiovascular systems (58) 58
medicine & public health (58) 58
percutaneous coronary intervention (58) 58
argatroban anticoagulation (56) 56
heparin - therapeutic use (55) 55
care and treatment (53) 53
pipecolic acids - pharmacology (53) 53
antithrombins - therapeutic use (52) 52
thrombocytopenia - diagnosis (52) 52
direct thrombin inhibitor (50) 50
hemodialysis (48) 48
aged, 80 and over (47) 47
hit (47) 47
risk factors (47) 47
pipecolic acids - adverse effects (45) 45
thrombosis - drug therapy (44) 44
dose-response relationship, drug (43) 43
hirudin (43) 43
surgery (43) 43
anticoagulants - pharmacology (41) 41
danaparoid (41) 41
blood coagulation - drug effects (40) 40
dosage and administration (40) 40
drug therapy (38) 38
international normalized ratio (38) 38
animals (37) 37
patient (37) 37
anesthesiology (36) 36
thrombocytopenia - therapy (35) 35
cardiology (34) 34
health aspects (34) 34
heparin‐induced thrombocytopenia (34) 34
peptide fragments - therapeutic use (34) 34
pharmacokinetics (34) 34
research (34) 34
heparin - administration & dosage (33) 33
platelet count (33) 33
thromboembolism (33) 33
pipecolic acids - pharmacokinetics (32) 32
platelet aggregation inhibitors - therapeutic use (32) 32
thrombin inhibitor (32) 32
acute myocardial-infarction (31) 31
antithrombins - administration & dosage (31) 31
renal replacement therapy (31) 31
thrombolysis (31) 31
complications and side effects (30) 30
patients (30) 30
hirudins (29) 29
prevention (29) 29
thrombosis - prevention & control (29) 29
venous limb gangrene (29) 29
coagulation (28) 28
prothrombin time (28) 28
risk (28) 28
thrombocytopenia - complications (28) 28
pharmacodynamics (27) 27
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 08/2017, Volume 12, Issue 8, p. e0182491
Journal Article
Blood Coagulation & Fibrinolysis, ISSN 0957-5235, 12/2019, Volume 30, Issue 8, pp. 426 - 428
.... The first case was a woman with abdominal arterial thrombosis, of unknown cause, treated with therapeutic low molecular weight heparin that developed pulmonary embolism despite therapeutic anticoagulation... 
heparin resistance | antithrombin | thrombosis | HEMATOLOGY | argatroban | Acute Disease | Humans | Middle Aged | Pipecolic Acids - therapeutic use | Adult | Anticoagulants - therapeutic use | Female | Male | Thrombosis - drug therapy | Drug Resistance | Heparin - pharmacology | Argatroban | Health aspects | Thrombosis | Blood clot
Journal Article
Journal Article
Journal Article
Pediatric Clinics of North America, ISSN 0031-3955, 12/2017, Volume 64, Issue 6, pp. 1257 - 1269
Journal Article